Literature DB >> 30394644

Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care.

Stephen J Greene1,2, G Michael Felker1,2, Javed Butler3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30394644      PMCID： PMC6333499          DOI： 10.1002/ejhf.1341

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  18 in total

1.  Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

Authors:  Marco Metra; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Margaret F Prescott; Christopher Edwards; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas Severin; John R Teerlink
Journal:  J Am Coll Cardiol       Date:  2013-01-15       Impact factor: 24.094

2.  Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.

Authors:  Stephen J Greene; Javed Butler; Gregg C Fonarow; Haris P Subacius; Andrew P Ambrosy; Muthiah Vaduganathan; Marco Triggiani; Scott D Solomon; Eldrin F Lewis; Aldo P Maggioni; Michael Böhm; Ovidiu Chioncel; Savina Nodari; Michele Senni; Faiez Zannad; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2017-10-17       Impact factor: 15.534

3.  Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.

Authors:  Yuya Matsue; Kevin Damman; Adriaan A Voors; Nobuyuki Kagiyama; Tetsuo Yamaguchi; Shunsuke Kuroda; Takahiro Okumura; Keisuke Kida; Atsushi Mizuno; Shogo Oishi; Yasutaka Inuzuka; Eiichi Akiyama; Ryuichi Matsukawa; Kota Kato; Satoshi Suzuki; Takashi Naruke; Kenji Yoshioka; Tatsuya Miyoshi; Yuichi Baba; Masayoshi Yamamoto; Koji Murai; Kazuo Mizutani; Kazuki Yoshida; Takeshi Kitai
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

4.  Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.

Authors:  Stephen J Greene; Adrian F Hernandez; Allison Dunning; Andrew P Ambrosy; Paul W Armstrong; Javed Butler; Lukasz P Cerbin; Adrian Coles; Justin A Ezekowitz; Marco Metra; Randall C Starling; John R Teerlink; Adriaan A Voors; Christopher M O'Connor; Robert J Mentz
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

5.  Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.

Authors:  Hicham Skali; Edward M Dwyer; Robert Goldstein; Mark Haigney; Ronald Krone; Marrick Kukin; Edgar Lichstein; Scott McNitt; Arthur J Moss; Marc A Pfeffer; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2014-02-27       Impact factor: 15.534

6.  Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).

Authors:  Thomas D Cook; Stephen J Greene; Andreas P Kalogeropoulos; Gregg C Fonarow; Ryan Zea; Karl Swedberg; Faiez Zannad; Aldo P Maggioni; Marvin A Konstam; Mihai Gheorghiade; Javed Butler
Journal:  Am J Cardiol       Date:  2015-12-08       Impact factor: 2.778

7.  A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.

Authors:  Adriaan A Voors; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos Filippatos; Pim van der Harst; Hans L Hillege; Chim C Lang; Jozine M Ter Maaten; Leong Ng; Piotr Ponikowski; Nilesh J Samani; Dirk J van Veldhuisen; Faiz Zannad; Aeilko H Zwinderman; Marco Metra
Journal:  Eur J Heart Fail       Date:  2016-04-29       Impact factor: 15.534

8.  Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures.

Authors:  Michael R Zile; Tom D Bennett; Martin St John Sutton; Yong K Cho; Philip B Adamson; Mark F Aaron; Juan M Aranda; William T Abraham; Frank W Smart; Lynne Warner Stevenson; Fred J Kueffer; Robert C Bourge
Journal:  Circulation       Date:  2008-09-15       Impact factor: 29.690

9.  Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).

Authors:  Naoki Okumura; Pardeep S Jhund; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Karl Swedberg; Michael R Zile; Scott D Solomon; Milton Packer; John J V McMurray
Journal:  Circulation       Date:  2016-04-20       Impact factor: 29.690

10.  Repeated hospitalizations predict mortality in the community population with heart failure.

Authors:  Soko Setoguchi; Lynne Warner Stevenson; Sebastian Schneeweiss
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749
View more
  5 in total

Review 1.  Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Authors:  Javed Butler; Milton Packer; Stephen J Greene; Mona Fiuzat; Stefan D Anker; Kevin J Anstrom; Peter E Carson; Lauren B Cooper; Gregg C Fonarow; Adrian F Hernandez; James L Januzzi; Mariell Jessup; Rita R Kalyani; Sanjay Kaul; Mikhail Kosiborod; JoAnn Lindenfeld; Darren K McGuire; Marc S Sabatine; Scott D Solomon; John R Teerlink; Muthiah Vaduganathan; Clyde W Yancy; Norman Stockbridge; Christopher M O'Connor
Journal:  Circulation       Date:  2019-12-16       Impact factor: 29.690

2.  Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.

Authors:  Douglas L Mann; Stephen J Greene; Michael M Givertz; Justin M Vader; Randall C Starling; Andrew P Ambrosy; Palak Shah; Steven E McNulty; Claudius Mahr; Divya Gupta; Margaret M Redfield; Anuradha Lala; Gregory D Lewis; Selma F Mohammed; Nisha A Gilotra; Adam D DeVore; Eiran Z Gorodeski; Patrice Desvigne-Nickens; Adrian F Hernandez; Eugene Braunwald
Journal:  JACC Heart Fail       Date:  2020-06-10       Impact factor: 12.035

3.  Recognizing the Significance of Outpatient Worsening Heart Failure.

Authors:  Muhammad Shahzeb Khan; Javed Butler; Stephen J Greene
Journal:  J Am Heart Assoc       Date:  2020-07-14       Impact factor: 5.501

4.  Initiation and long-term use of tolvaptan for patients with worsening heart failure through hospital and clinic cooperation.

Authors:  Yusuke Uemura; Rei Shibata; Shinji Ishikawa; Kenji Takemoto; Toyoaki Murohara; Masato Watarai
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

5.  Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study.

Authors:  Antonio D'Onofrio; Francesco Solimene; Leonardo Calò; Valeria Calvi; Miguel Viscusi; Donato Melissano; Vitantonio Russo; Antonio Rapacciuolo; Andrea Campana; Fabrizio Caravati; Paolo Bonfanti; Gabriele Zanotto; Edoardo Gronda; Antonello Vado; Vittorio Calzolari; Giovanni Luca Botto; Massimo Zecchin; Luca Bontempi; Daniele Giacopelli; Alessio Gargaro; Luigi Padeletti
Journal:  Europace       Date:  2022-02-02       Impact factor: 5.214
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.